Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Non-Current Assets (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Non-Current Assets for 5 consecutive years, with $313921.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Non-Current Assets fell 69.17% year-over-year to $313921.0, compared with a TTM value of $627842.0 through Sep 2025, down 84.59%, and an annual FY2024 reading of $313921.0, down 69.17% over the prior year.
  • Non-Current Assets was $313921.0 for Q1 2025 at Xenetic Biosciences, roughly flat from $313921.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.0 million in Q4 2023 and bottomed at $313921.0 in Q4 2024.
  • Average Non-Current Assets over 3 years is $772727.0, with a median of $844431.0 recorded in 2023.
  • Peak annual rise in Non-Current Assets hit 44.56% in 2024, while the deepest fall reached 69.17% in 2024.
  • Year by year, Non-Current Assets stood at $1.0 million in 2023, then plummeted by 69.17% to $313921.0 in 2024, then changed by 0.0% to $313921.0 in 2025.
  • Business Quant data shows Non-Current Assets for XBIO at $313921.0 in Q1 2025, $313921.0 in Q4 2024, and $1.0 million in Q3 2024.